These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8312108)

  • 1. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1993; 14():353-70. PubMed ID: 8312108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimicrobial therapy in neutropenia].
    Maschmeyer G; Vogt K; Hahn H; Dörken B
    Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost effectiveness of myeloid growth factors in cancer chemotherapy.
    Lyman GH; Kuderer NM
    Curr Hematol Rep; 2003 Nov; 2(6):471-9. PubMed ID: 14561391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the management of chemotherapy-induced neutropenia.
    Dale DC
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):679-84. PubMed ID: 16258470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematopoietic growth factors in oncology and hematology. Recommendations for more cost-efficient use].
    Paul C; Hast R
    Lakartidningen; 2000 Jun; 97(23):2862-6. PubMed ID: 10885223
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 10. Current and future use of hematopoietic growth factors in cancer medicine.
    Mughal TI
    Hematol Oncol; 2004 Sep; 22(3):121-34. PubMed ID: 15991222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing hematologic toxicities.
    Capo G; Waltzman R
    J Support Oncol; 2004; 2(1):65-79. PubMed ID: 15330374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of myeloid growth factors in hemato-oncology.
    Boogaerts MA
    Acta Clin Belg; 1999 Oct; 54(5):312-5. PubMed ID: 10555392
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopoietic growth factors in cancer chemotherapy.
    Lieschke GJ; Foote M; Morstyn G
    Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
    [No Abstract]   [Full Text] [Related]  

  • 14. New developments in the use of cytokines for cancer therapy.
    Maini A; Morse PD; Wang CY; Jones RF; Haas GP
    Anticancer Res; 1997; 17(5B):3803-8. PubMed ID: 9427784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors in the management of adult acute leukemia.
    Bernstein SH
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):255-74. PubMed ID: 8449861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of peripheral blood progenitor cells by hematopoietic growth factors.
    Chao NJ
    Can J Oncol; 1995 Dec; 5 Suppl 1():43-6. PubMed ID: 8853524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute leukemia].
    Sánchez-Cortés E; González-Llaven J
    Rev Invest Clin; 1997 May; 49 Suppl 1():103-7. PubMed ID: 9380982
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hematopoietic growth factors in iatrogenic neutropenia in oncology].
    Klastersky J
    Rev Mal Respir; 1995; 12(5):407-8. PubMed ID: 8560070
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematopoietic growth factors in hematological malignancies.
    Kumar R; Rao RR; Ranjan S
    J Assoc Physicians India; 1995; Suppl 3():5-10. PubMed ID: 8773114
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of haematopoietic growth factors: defining relevant clinical endpoints in growth factor trials.
    Linch DC
    Eur J Cancer; 1994; 30A Suppl 3():S40-3. PubMed ID: 7695958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.